Publications
29 Jun 2009
White paper recommends regulation of hedge fund managers
Alternative Asset Management Alert
The Obama Administration's comprehensive financial regulatory reform plan proposes several changes that, if implemented, will subject fund managers and their investment vehicles to SEC oversight and additional disclosure requirements.
Set out in an 88-page White Paper, the plan’s overall aim is to modernize and protect the integrity of the US financial system.
Although the recommendations summarized below are components of the proposed financial overhaul, they have not yet been formalized by any legislation or regulation.
The White Paper proposes a
registration requirement under the Investment Advisers Act of 1940 (the Advisers Act) for all investment advisers of hedge funds (and other private pools of capital, including private equity funds and venture capital funds) whose assets under management exceed “some modest threshold,” which is yet to be determined. In addition, the White Paper
recommends certain obligations for investment funds advised by a registered investment adviser, including (i) recordkeeping requirements; (ii) additional requirements with respect to disclosures to investors, creditors and counterparties; and (iii) regulatory reporting requirements. The regulatory reporting requirements would mandate that funds report to the Securities and Exchange Commission the amount of assets under management, details regarding the fund’s borrowings, off-balance sheet exposures and other information necessary to “assess whether the fund or fund family is so large, highly leveraged, or interconnected that it poses a threat to financial stability.” A fund or fund family that poses such a threat would be
subject to additional regulation and supervision by the Federal Reserve.
The White Paper also proposes
comprehensive regulation of all over-the-counter derivatives. Currently, OTC derivatives markets are largely unregulated. Although the CFTC and SEC currently have limited statutory authority to regulate OTC derivatives, the White Paper recommends amendments to the commodities and securities laws to require clearing of all standardized OTC derivatives through regulated central counterparties. CCPs would be required to impose robust margin requirements, as well as other necessary risk controls.
In addition, the White Paper calls for
extra scrutiny of customized OTC derivatives to ensure they are not being used solely to avoid using a CCP. It emphasizes that future amendments to the commodities and securities laws must “ensure that the CFTC and SEC…have clear, unimpeded authority to police and prevent fraud, market manipulation, and other market abuses involving all OTC derivatives.”
Guidance on harmonization of futures and securities regulation is also a focus of the White Paper. The White Paper recommends an amendment of the current federal regulatory structure to eliminate jurisdictional uncertainties between the CFTC and SEC, and building a common foundation for market regulation through interagency agreement.
Finally, the White Paper urges
international cooperation on the regulation of hedge funds and their managers, recommending national authorities implement, by the end of 2009, the G-20 commitment to require hedge fund registration and disclosure obligations so that regulators can assess any systemic risk these investment vehicles pose individually or collectively.
Please
read the full text of the White Paper here.
We will alert you to further developments as to the status of the White Paper proposals as they progress towards implementation.
For more information, please contact
your DLA Piper lawyer.
This information is intended as a general overview and discussion of the subjects dealt with. The information provided here was accurate as of the day it was posted; however, the law may have changed since that date. This information is not intended to be, and should not be used as, a substitute for taking legal advice in any specific situation. DLA Piper is not responsible for any actions taken or not taken on the basis of this information. Please refer to the full terms and conditions on our website.
Copyright © 2012 DLA Piper. All rights reserved.